LABORATORY CORPORATION OF AMERICA HOLDINGS 2023-2024 Proxy Voting Records

Description as filed by funds: Election of the members of the Company's Board of Directors: Adam H. Schechter

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“Elect Director: Adam H. Schechter”): 66,696,331 for, 3,866,647 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2025 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 29,136,328 for, 19,458 against, 3,406 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: D. Gary Gilliland, M.D., Ph.D.

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“Elect Director: D. Gary Gilliland, M.D., Ph.D.”): 70,026,112 for, 666,813 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2025 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 29,155,786 for, 3,406 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Garheng Kong, M.D., Ph.D.

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“Elect Director: Garheng Kong, M.D., Ph.D.”): 68,880,113 for, 1,816,173 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2025 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 29,155,786 for, 3,406 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Jeffrey A. Davis

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“Elect Director: Jeffrey A. Davis”): 70,603,583 for, 89,968 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2025 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 29,155,786 for, 3,406 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Kathryn E. Wengel

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“Elect Director: Kathryn E. Wengel”): 45,457,646 for, 25,179,174 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2025 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 64% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 21,650,328 for, 7,505,458 against, 3,406 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Kerrii B. Anderson

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“Elect Director: Kerrii B. Anderson”): 65,317,209 for, 5,379,339 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2025 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 27,334,583 for, 1,821,203 against, 3,406 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Kirsten M. Kliphouse

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“Elect Director: Kirsten M. Kliphouse”): 70,637,639 for, 59,699 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2025 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 29,155,786 for, 3,406 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Paul B. Rothman, M.D.

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“Elect Director: Paul B. Rothman, M.D.”): 70,622,022 for, 73,434 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2025 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 29,155,786 for, 3,406 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Peter M. Neupert

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“Elect Director: Peter M. Neupert”): 67,187,525 for, 3,507,269 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2025 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 28,009,587 for, 1,146,199 against, 3,406 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: Election of the members of the Company's Board of Directors: Richelle P. Parham

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“Elect Director: Richelle P. Parham”): 68,403,353 for, 2,291,498 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2025 Annual Meeting of Shareholders or until their successors are elected and qualified or until their…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 29,147,201 for, 8,585 against, 3,406 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: To approve, by non-binding vote, the compensation of the Laboratory Corporation of America Holdings' named executive officers.

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“2. In an advisory (non-binding) vote, the compensation of the Company's named executive officers”): 65,007,331 for, 5,566,884 against — passed, per its Form 8-K filed May 16, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's shareholders approved in an advisory (non-binding) vote, the compensation of the Company's named executive officers.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 109 managers: 29,102,599 for, 53,175 against, 3,406 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 370 managers: 55,228,022 for, 3,621,019 against, 26,600 abstained, 12,867 not voted, 75,181 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2024.

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“3. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024”): 76,120,507 for, 832,250 against — passed, per its Form 8-K filed May 16, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's shareholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 29,155,786 for, 3,406 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: Shareholder proposal regarding shareholder opportunity to vote on excessive golden parachutes.

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“4. The shareholder proposal requesting adoption of a policy regarding shareholder opportunity to vote on excessive golden parachutes”): 5,219,140 for, 65,530,226 against — failed, per its Form 8-K filed May 16, 2024 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “The Company's shareholders did not approve the shareholder proposal requesting adoption of a policy regarding shareholder opportunity to vote on excessive golden parachutes.”
Support: 7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 100,087 for, 25,211,386 against, 2,783 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: Shareholder proposal regarding a Board report on transport of nonhuman primates within the U.S.

LABORATORY CORPORATION OF AMERICA HOLDINGS’s own tally for this item (“5. The shareholder proposal seeking an annual Board report on the transport of nonhuman primates within the United States”): 5,787,586 for, 64,071,818 against — failed, per its Form 8-K filed May 16, 2024 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “The Company's shareholders did not approve the shareholder proposal seeking an annual Board report on the transport of nonhuman primates within the United States.”
Support: 8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 119,383 for, 28,972,133 against, 67,676 abstained.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

The 106 asset managers below reported 1,352,471 for, 23,769,479 against, 191,570 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 106 asset managers. See all 106 in the interactive database.